UCL Institute of Neurology
Research and teaching excellence
The Institute of Neurology has a world class reputation for neuroscience. The mission is to translate neuroscience discovery research into treatments for patients with neurological diseases. A number of important research centres are based at the Institute, including the MRC Prion Unit, MRC Centre for Neuromuscular Diseases and the Wellcome Trust Centre for Neuroimaging
Professor Michael Hanna is the Director of the Institute, which is a specialist postgraduate institute of University College London, the top-ranked university in the UK for research in Psychology, Psychiatry and Neuroscience.
The Institute is closely associated in its work with the National Hospital for Neurology & Neurosurgery. In combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.
What We Do
Please see our Infographic highlighting key data on the Institute.
Institute of Neurology team at Red Bull F1 with Sir Jackie Stewart - innovation key in fight against dementia
UCL Institute of Neurology have recently formed a link with Sir Jackie Stewart and his new charity “Race Against Dementia”
Published: Feb 17, 2017 2:29:51 PM
A new clinical trial at the LWENC CRF to test a potential disease-modifying agent in Parkinson’s disease – the AIM-PD trial
A new trial that investigates whether a drug called ABX can influence the levels of a crucial enzyme in patients with Parkinson’s disease (PD) has recently started at the Leonard Wolfson Experimental Neurology Centre (LWENC) Clinical Research Facility (CRF), based at the UCL Institute of Neurology, the Royal Free London hospital and the National Hospital for Neurology and Neurosurgery (UCLH).
Published: Feb 17, 2017 2:09:55 PM
The core mission of UCL Institute of Neurology is to translate discovery science into new diagnostics and ultimately treatments for patients with neurological diseases. Bidirectional patient and public engagement is a central part of this strategy.
Published: Feb 16, 2017 6:31:33 PM